abstract |
Disclosed are compositions and uses thereof for the treatment of cancer, such as ovarian cancer. Provided is an isolated antibody that specifically binds to SEQ ID NO:392, at an amino acid sequence selected from the group consisting of: SEQ ID NOs: 394-415; from SEQ ID NO:392 amino acid residues 31-65; 61-80; 76-110; 136-200 and 226-245. |